84 related articles for article (PubMed ID: 8646252)
1. The effects of weight loss on insulin sensitivity, skeletal muscle composition and capillary density in obese non-diabetic subjects.
Niskanen L; Uusitupa M; Sarlund H; Siitonen O; Paljärvi L; Laakso M
Int J Obes Relat Metab Disord; 1996 Feb; 20(2):154-60. PubMed ID: 8646252
[TBL] [Abstract][Full Text] [Related]
2. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients.
Nam SY; Kim KR; Cha BS; Song YD; Lim SK; Lee HC; Huh KB
Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1101-7. PubMed ID: 11477493
[TBL] [Abstract][Full Text] [Related]
3. Changes in glucose and lipid metabolism following weight loss produced by a very low calorie diet in obese subjects.
Bryson JM; King SE; Burns CM; Baur LA; Swaraj S; Caterson ID
Int J Obes Relat Metab Disord; 1996 Apr; 20(4):338-45. PubMed ID: 8680461
[TBL] [Abstract][Full Text] [Related]
4. Elevated fasting insulin concentrations associate with impaired insulin signaling in skeletal muscle of healthy subjects independent of obesity.
Korsheninnikova E; Seppälä-Lindroos A; Vehkavaara S; Goto T; Virkamäki A
Diabetes Metab Res Rev; 2002; 18(3):209-16. PubMed ID: 12112939
[TBL] [Abstract][Full Text] [Related]
5. Regulation of skeletal muscle morphology in type 2 diabetic subjects by troglitazone and metformin: relationship to glucose disposal.
Mathieu-Costello O; Kong A; Ciaraldi TP; Cui L; Ju Y; Chu N; Kim D; Mudaliar S; Henry RR
Metabolism; 2003 May; 52(5):540-6. PubMed ID: 12759881
[TBL] [Abstract][Full Text] [Related]
6. The effects of weight loss in obese subjects on the thermogenic, metabolic and haemodynamic responses to the glucose clamp.
Webber J; Donaldson M; Allison SP; Fukagawa NK; Macdonald IA
Int J Obes Relat Metab Disord; 1994 Nov; 18(11):725-30. PubMed ID: 7866471
[TBL] [Abstract][Full Text] [Related]
7. Effect of weight loss on muscle fiber type, fiber size, capillarity, and succinate dehydrogenase activity in humans.
Kern PA; Simsolo RB; Fournier M
J Clin Endocrinol Metab; 1999 Nov; 84(11):4185-90. PubMed ID: 10566670
[TBL] [Abstract][Full Text] [Related]
8. Lower capillary density but no difference in VEGF expression in obese vs. lean young skeletal muscle in humans.
Gavin TP; Stallings HW; Zwetsloot KA; Westerkamp LM; Ryan NA; Moore RA; Pofahl WE; Hickner RC
J Appl Physiol (1985); 2005 Jan; 98(1):315-21. PubMed ID: 15298982
[TBL] [Abstract][Full Text] [Related]
9. Skeletal muscle triglycerides lowering is associated with net improvement of insulin sensitivity, TNF-alpha reduction and GLUT4 expression enhancement.
Mingrone G; Rosa G; Di Rocco P; Manco M; Capristo E; Castagneto M; Vettor R; Gasbarrini G; Greco AV
Int J Obes Relat Metab Disord; 2002 Sep; 26(9):1165-72. PubMed ID: 12187392
[TBL] [Abstract][Full Text] [Related]
10. Fat oxidation, body composition and insulin sensitivity in diabetic and normoglycaemic obese adults 5 years after weight loss.
Poynten AM; Markovic TP; Maclean EL; Furler SM; Freund J; Chisholm DJ; Campbell LV
Int J Obes Relat Metab Disord; 2003 Oct; 27(10):1212-8. PubMed ID: 14513069
[TBL] [Abstract][Full Text] [Related]
11. Reversibility of insulin resistance in obese diabetic patients: role of plasma lipids.
Mingrone G; DeGaetano A; Greco AV; Capristo E; Benedetti G; Castagneto M; Gasbarrini G
Diabetologia; 1997 May; 40(5):599-605. PubMed ID: 9165230
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial capacity in skeletal muscle is not stimulated by weight loss despite increases in insulin action and decreases in intramyocellular lipid content.
Toledo FG; Menshikova EV; Azuma K; Radiková Z; Kelley CA; Ritov VB; Kelley DE
Diabetes; 2008 Apr; 57(4):987-94. PubMed ID: 18252894
[TBL] [Abstract][Full Text] [Related]
13. Physical training in the prophylaxis and treatment of obesity, hypertension and diabetes.
Krotkiewski M
Scand J Rehabil Med Suppl; 1983; 9():55-70. PubMed ID: 6372078
[TBL] [Abstract][Full Text] [Related]
14. Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease.
Meyer MM; Levin K; Grimmsmann T; Beck-Nielsen H; Klein HH
Diabetologia; 2002 Jun; 45(6):813-22. PubMed ID: 12107725
[TBL] [Abstract][Full Text] [Related]
15. Skeletal muscle capillary responses to insulin are abnormal in late-stage diabetes and are restored by angiotensin-converting enzyme inhibition.
Clerk LH; Vincent MA; Barrett EJ; Lankford MF; Lindner JR
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1804-9. PubMed ID: 17911341
[TBL] [Abstract][Full Text] [Related]
16. Exercise training versus diet-induced weight-loss on metabolic risk factors and inflammatory markers in obese subjects: a 12-week randomized intervention study.
Christiansen T; Paulsen SK; Bruun JM; Pedersen SB; Richelsen B
Am J Physiol Endocrinol Metab; 2010 Apr; 298(4):E824-31. PubMed ID: 20086201
[TBL] [Abstract][Full Text] [Related]
17. Non-oxidative glucose disposal is reduced in type 2 diabetes, but can be restored by aerobic exercise.
Yokoyama H; Mori K; Emoto M; Araki T; Teramura M; Mochizuki K; Tashiro T; Motozuka K; Inoue Y; Nishizawa Y
Diabetes Obes Metab; 2008 May; 10(5):400-7. PubMed ID: 18410564
[TBL] [Abstract][Full Text] [Related]
18. Effects of physical activity and weight loss on skeletal muscle mitochondria and relationship with glucose control in type 2 diabetes.
Toledo FG; Menshikova EV; Ritov VB; Azuma K; Radikova Z; DeLany J; Kelley DE
Diabetes; 2007 Aug; 56(8):2142-7. PubMed ID: 17536063
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesity.
Laine H; Yki-Jarvinen H; Kirvela O; Tolvanen T; Raitakari M; Solin O; Haaparanta M; Knuuti J; Nuutila P
J Clin Invest; 1998 Mar; 101(5):1156-62. PubMed ID: 9486987
[TBL] [Abstract][Full Text] [Related]
20. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.
Golay A; Defronzo RA; Thorin D; Jequier E; Felber JP
Diabete Metab; 1988; 14(4):443-51. PubMed ID: 3066652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
